Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: Randomized, double-blind, 5-year phase II study in healthy adults

by Peter E. Nasveld, Andrew Ebringer, Nathan Elmes, Sonya Bennett, Sutee Yoksan, John Aaskov, Karen McCarthy, Niranjan Kanesa-thasan, Claude Meric, Mark Reid
Published 2018

Clinical proof of principle for ChimeriVax™: Recombinant live, attenuated vaccines against flavivirus infections

by Thomas P. Monath, Karen McCarthy, Philip Bedford, Casey T. Johnson, Richard Nichols, Sutee Yoksan, Ron Marchesani, Michael Knauber, Keith H. Wells, Juan Arroyo, Farshad Guirakhoo
Published 2018

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™- DEN2) vaccine: Phase I clinical trial for safety and immunogenicity - Effect of yellow fever pre-immunity in induc...

by Farshad Guirakhoo, Scott Kitckener, Dennis Morrison, Remi Forrat, Karen McCarthy, Richard Nichols, Sutee Yoksan, Xiaochu Duan, Thomas H. Ermak, Niranjan Kanesa-Thasan, Philip Bedford, Jean Lang, Marie Jose Quentin-Millet, Thomas P. Monath
Published 2018